Quick Takeaways
- BML Investment Partners, L.P. filed SCHEDULE 13G/A for Athira Pharma Inc. Common Stock, $0.0001 par value (ATHA).
- Disclosed ownership: 0%.
- Date of event: 18 Dec 2025.
BML Investment Partners, L.P. - 18 Dec 2025 SCHEDULE 13G/A Report for Athira Pharma Inc. Common Stock, $0.0001 par value (ATHA)
- Filing Manager
- BML Investment Partners, L.P.
- Reporting Manager
- BML Investment Partners, L.P.
- Symbol
- ATHA
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Dec 2025, 15:47:45 UTC
- Date of event
- 18 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BML Investment Partners, L.P. disclosed 0% ownership in Athira Pharma Inc. Common Stock, $0.0001 par value (ATHA) on 18 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 18 Dec 2025, 15:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 0% | 0 | 0 | 0 | Braden M Leonard | BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member | |
| Leonard Braden Michael | 0% | 0 | 0 | 0 | Braden M Leonard | Leonard Braden Michael |